Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
Taichun Qin, Ryan Castoro, Samih El Ahdab et al. · PLoS ONE · 2011
Full textCC BY
Hematology
Filters2 filters applied
Status
Year
Readable here
Study type
86 papers2 CorrectedQuestions on this topic
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
Julien Rocquain, Nadine Carbuccia, Virginie Trouplin et al. · BMC Cancer · 2010
Full textCC BY
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
Colin A Hutchison, Tim Plant, Mark Drayson et al. · BMC Nephrology · 2008
Full textCC BY
The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis
Daniel R. Carrasco, Kumar Sukhdeo, Marina Protopopova et al. · Cancer Cell · 2007
Full textCC BY
Interleukin-1β induced vascular permeability is dependent on induction of endothelial Tissue Factor (TF) activity
Markus Puhlmann, David M Weinreich, Jeffrey M Farma et al. · Journal of Translational Medicine · 2005
Full textCC BY
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
J A Glaspy, J S Jadeja, G Justice et al. · British Journal of Cancer · 2002 · Randomised trial
Full textCC BY